# Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

> **NCT06888973** · PHASE1,PHASE2 · ENROLLING_BY_INVITATION · sponsor: **National Institute of Blood and Marrow Transplant (NIBMT), Pakistan** · enrollment: 200 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Systemic Sclerosis
- Ankylosing Spondylitis (AS)
- Juvenile Idiopathic Arthritis
- Polymyositis/Dermatomyositis

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cells
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06888973
- **Lead sponsor:** National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-02-01
- **Primary completion:** 2025-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06888973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06888973, "Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases". Retrieved via AI Analytics 2026-09-06 from https://api.ai-analytics.org/clinical/NCT06888973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*